loperamide has been researched along with peptide yy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, H; Kanatani, A; Kanno, T; Moriya, R; Shirakura, T; Suzuki, J | 1 |
| Hirotani, Y; Ikeda, K; Kurokawa, N; Mikajiri, K; Myotoku, M | 1 |
2 other study(ies) available for loperamide and peptide yy
| Article | Year |
|---|---|
NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.
Topics: Animals; Antidiarrheals; Diarrhea; Disease Models, Animal; Gastrointestinal Transit; Humans; Intestinal Secretions; Loperamide; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y | 2010 |
Changes of intestinal mucosal and plasma PYY in a diarrhea model rat and influence of loperamide as the treatment agent for diarrhea.
Topics: Animals; Antidiarrheals; Diarrhea; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Motility; Intestinal Mucosa; Loperamide; Peptide YY; Radioimmunoassay; Rats; Rats, Wistar | 2008 |